Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Nishimura (Obu, Aichi, Japan), M. Kusunose (Obu, Aichi, Japan), R. Sanda (Obu, Aichi, Japan), M. Mori (Obu, Aichi, Japan), A. Shibayama (Obu, Aichi, Japan). Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.. 1595

Member's Comments

No comment yet.

Related content which might interest you: Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (3) 00068-2021; 10.1183/23120541.00068-2021 Year: 2021 Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Clinical parameters for predicting 3-month FEV1 response of obstructive lung diseases in elderly patients Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China Source: International Congress 2017 – COPD biomarkers Year: 2017 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Interpreting blood eosinophil counts in health and obstructive lung disease Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021 Year: 2022 Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data. Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Cross-sectional study on therapeutic adherence and disease knowledge of patients affected by chronic obstructive pulmonary disease. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017 Year: 2017 Usefulness and relationship of clinical dyspnoea ratings with health status in chronic obstructive pulmonary disease patients Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: management Year: 2010 Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005